Adicet Bio, Inc. Debt Securities, Available-for-sale
Adicet Bio, Inc. (ACET) had Debt Securities, Available-for-sale of $85.06 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-08-05
- 2026-06-30: Debt Securities, Available-for-sale $85.06M.
- 2026-03-31: Debt Securities, Available-for-sale $101.35M.
- 2025-12-31: Debt Securities, Available-for-sale $119.61M.
- 2025-09-30: Debt Securities, Available-for-sale $74.00M.
| Period end | Debt Securities, Available-for-sale | Debt Securities, Available-for-sale as first filed |
|---|---|---|
| 2026-06-30 | $85.06M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $101.35M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $119.61M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $74.00M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $90.24M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $122.31M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $119.81M 10-K · filed 2026-03-12 | |
| 2021-03-31 | $1.75M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $10.28M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $23.16M 10-Q · filed 2020-11-05 | |
| 2020-03-31 | $15.11M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $62.38M 10-K · filed 2021-03-12 | $57.70M 10-K · filed 2020-03-12 |
| 2019-09-30 | $93.64M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $111.42M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $135.91M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $100.99M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $92.52M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $74.57M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |